Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Phase IIb trial results confirm efficacy and safety of INKP-100 for colonoscopy

Sep. 21, 1998

Pylorid-containing triple therapy effective in eradicating H. pylori

Sep. 16, 1998

Early clinical trial results reported for cilansetron at recent congress

Sep. 14, 1998

Celgene successfully completes phase I multiple-dose trial of lead SelCID compound

Sep. 14, 1998

Role of oral porcine spasmolytic polypeptide in GI disorders studied by Danish group

Sep. 14, 1998

Antisense oligodeoxynucleotide to rat ICAM-1 tested in rat model of enterocolitis

Sep. 14, 1998

Preclinical and clinical data support potential of MKC-733 in GI motor disorders

Sep. 11, 1998

Early clinical results reported for osutidine, an H2 antagonist from Toyama

Sep. 10, 1998

Antisecretory and antiulcer effects of S-0509 characterized in rats

Sep. 10, 1998

KW-5139 effective for reducing gastric stasis following pancreatoduodenectomy

Sep. 10, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...